Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

Inclusion Criteria: * Have characteristics of Behcet's disease consistent with International Criteria for Behcet's disease * Have a documented history of active uveitis with or without retinal vasculitis within the past 12 months * Best corrected visual acuity (BCVA) \>= 20 ETDRS letters in both eyes at baseline * Effective contraceptive measures Exclusion Criteria: * Infectious uveitis and masquerade syndromes * End stage ocular disease * History of allergic or anaphylactic reactions to monoclonal antibodies * Active tuberculosis disease * History of recurrent infection or predisposition to infection; active ocular infection * Pregnant or nursing women Other protocol-defined inclusion/exclusion criteria may apply